Judith
0000-0002-0762-6415
4 papers found
Refreshing results…
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study
Association of premenopausal risk-reducing salpingo-oophorectomy with breast cancer risk in BRCA1/2 mutation carriers: Maximising bias-reduction
A RAD 51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Missing publications? Search for publications with a matching author name.